1012 related articles for article (PubMed ID: 25220381)
1. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
2. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
[TBL] [Abstract][Full Text] [Related]
3. [Puberty-delaying hormone therapy in adolescents with gender identity disorder].
Nakatsuka M
Seishin Shinkeigaku Zasshi; 2013; 115(3):316-22. PubMed ID: 23691819
[TBL] [Abstract][Full Text] [Related]
4. Management of juvenile gender dysphoria.
Hembree WC
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
Schagen SE; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
J Sex Med; 2016 Jul; 13(7):1125-32. PubMed ID: 27318023
[TBL] [Abstract][Full Text] [Related]
6. Young adult psychological outcome after puberty suppression and gender reassignment.
de Vries AL; McGuire JK; Steensma TD; Wagenaar EC; Doreleijers TA; Cohen-Kettenis PT
Pediatrics; 2014 Oct; 134(4):696-704. PubMed ID: 25201798
[TBL] [Abstract][Full Text] [Related]
7. [Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
Nakatsuka M
Seishin Shinkeigaku Zasshi; 2012; 114(6):647-53. PubMed ID: 22844815
[TBL] [Abstract][Full Text] [Related]
8. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
9. Cross-sex hormone therapy for gender dysphoria.
Fabris B; Bernardi S; Trombetta C
J Endocrinol Invest; 2015 Mar; 38(3):269-82. PubMed ID: 25403429
[TBL] [Abstract][Full Text] [Related]
10. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.
Hembree WC; Cohen-Kettenis P; Delemarre-van de Waal HA; Gooren LJ; Meyer WJ; Spack NP; Tangpricha V; Montori VM;
J Clin Endocrinol Metab; 2009 Sep; 94(9):3132-54. PubMed ID: 19509099
[TBL] [Abstract][Full Text] [Related]
11. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adolescents with gender dysphoria in the Netherlands.
Cohen-Kettenis PT; Steensma TD; de Vries AL
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):689-700. PubMed ID: 22051006
[TBL] [Abstract][Full Text] [Related]
13. Self-perception of voice in transgender persons during cross-sex hormone therapy.
Bultynck C; Pas C; Defreyne J; Cosyns M; den Heijer M; T'Sjoen G
Laryngoscope; 2017 Dec; 127(12):2796-2804. PubMed ID: 28730692
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.
Oda H; Kinoshita T
BMC Psychiatry; 2017 Jul; 17(1):256. PubMed ID: 28716082
[TBL] [Abstract][Full Text] [Related]
15. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
Moore E; Wisniewski A; Dobs A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
[TBL] [Abstract][Full Text] [Related]
16. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
Hembree WC
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
[TBL] [Abstract][Full Text] [Related]
18. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
19. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function.
Schneider F; Kliesch S; Schlatt S; Neuhaus N
Andrology; 2017 Sep; 5(5):873-880. PubMed ID: 28914501
[TBL] [Abstract][Full Text] [Related]
20. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
